Skip to main content

Volume 3 Supplement 1


Clinical utility of repeated blood culture sampling in critically ILL neonates


Repeated blood culture sampling is common in critically ill neonates though precise indications are unknown.


To describe clinical characteristics driving repeated blood culture sampling: clinical indications, time interval between cultures, and rates of blood culture-positivity.


Prospective multicenter study of characteristics for repeated blood culture sampling in neonates admitted to three tertiary-referral intensive care units (period 7/2013-12/2014). Repeated blood culture samples were included when obtained within 14 days after the previous sample. Clinical sepsis is defined as the presence of 2 clinical signs and the duration of antibiotic therapy for ≥5 days. Blood cultures positive for skin commensals are considered contaminated if no 2 clinical signs and no CRP of > 2mg/dL are identified.


Of the 413 initial blood culture samples in 286 neonates, 132 (32%) were repeated blood cultures sampled in 97 neonates, 42 of which had a birth-weight ≤1500 g. Repeated cultures resulted in: (1) no sepsis, i.e. no growth (n = 87, 65.9%) and contamination (n = 5, 3.8%), (2) clinical sepsis (n = 25, 18.9%), and (3) lab-confirmed sepsis (n = 15, 11.4%). Clinical characteristics of repeated cultures for the total and those three cohorts are in Figure 1. Significant less clinical signs were observed between the cohort of neonates receiving prior antibiotic therapy (ABT, n = 95) vs no prior ABT (n = 37) (median 0 [IQR 0-1] vs median 1 [IQR 0-3], P =. 016); also shorter interval between cultures (median 5 [IQR 3-8] vs median 11 [IQR 9-13], P < .001) and higher CRP values (median 2 [IQR 1-4] vs median 1 [IQR 0-2], P < .001) were noticed. No significant difference in lab-confirmed sepsis was observed between the prior ABT vs no prior ABT cohort.

Figure 1
figure 1

Characteristics of 132 included cultures.


CRP rise seems not a good indicator for repeated blood culturing, though mostly identified as an indicator in particular in the prior-ABT-cohort. Prior ABT influences indications and interval for repeated cultures but has no effect on blood culture-positivity. Repeated blood culture samples seems indicated when ≥2 clinical signs occur.

Grant Acknowledgment

Grant by Belgian Research Fund (BOF)


  1. Al-Lawama MA, Badran EF: Clinical value of repeat blood cultures in neonatal patients receiving antibiotic treatment. J Int Med Res. 2015, 43 (1): 118-124. 10.1177/0300060514552154.

    Article  PubMed  Google Scholar 

  2. Tabriz MS, Riederer K, Baran J, Khatib R: Repeating blood cultures during hospital stay: practice pattern at a teaching hospital and a proposal for guidelines. Clin Microbiol Infect. 2004, 10 (7): 624-627. 10.1111/j.1469-0691.2004.00893.x.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Verstraete, E., Mahieu, L., Haese, J. et al. Clinical utility of repeated blood culture sampling in critically ILL neonates. ICMx 3 (Suppl 1), A556 (2015).

Download citation

  • Published:

  • DOI: